Clinical Trials

Showing trials with last updates posted in 2021.

NCT01845740 | COMPLETED | PHASE1
22 participants

Phase Ib Study of SC Milatuzumab in SLE

Study Type:
INTERVENTIONAL
Last Updated:
2021-08-19
Start Date:
2007-01-31
Completion:
2009-06-30
Conditions
  • Lupus Erythematosus, Cutaneous
  • Lupus Erythematosus, Discoid
  • Lupus Erythematosus, Systemic
  • Lupus Vasculitis, Central Nervous System
  • Lupus Nephritis
Interventions
  • DRUG
No Results Yet
NCT01742702 | RECRUITING
2000 participants

HaemoDYNAMICs in Primary and Secondary Hypertension

Study Type:
OBSERVATIONAL
Last Updated:
2021-08-19
Start Date:
2006-05-25
Completion:
2025-12-31
Conditions
  • Primary Hypertension
  • Secondary Hypertension
  • Aortic Stenosis
  • Renal Insufficiency
Interventions
  • DRUG
  • DIETARY_SUPPLEMENT
No Results Yet
NCT01663766 | TERMINATED | PHASE1
12 participants

Phase I Study of Milatuzumab for Graft Versus Host Disease

Study Type:
INTERVENTIONAL
Last Updated:
2021-08-19
Start Date:
2013-12-31
Completion:
2015-03-31
Conditions
  • GVHD (Acute or Chronic)
  • Acute Myeloid or Lymphoblastic Leukemia (AML or ALL)
  • Myelodysplastic Syndrome
  • Chronic Myelogenous Leukemia (CML)
  • Multiple Myeloma (MM)
  • Non-Hodgekin Lymphoma (NHL-both Follicular & Diffuse Large Cell)
  • Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia (CLL or SLL)
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page